Univerzitna Nemocnica Martin

At Univerzitna Nemocnica Martin, clinical research in digestive system diseases focuses strongly on ulcerative colitis and related inflammatory conditions in children and adolescents. These studies are designed to evaluate new treatment options and better long-term disease control.

• Inflammatory bowel disease, especially ulcerative colitis, in pediatric and adolescent patients
• Eosinophilic esophagitis and erosive esophagitis, with attention to symptom relief and healing
• Testing and comparing therapies aimed at improving remission, safety, and everyday digestive health

The site’s pediatric gastroenterology team contributes to studies that aim to improve both short-term symptom control and longer-term outcomes for young patients with chronic gastrointestinal disease.

This research area includes respiratory tract diseases and immune system diseases, with trials covering asthma, allergic rhinitis, bronchiectasis, and severe viral lung infections. The main goal is to test therapies that may reduce symptoms, prevent flare-ups, and improve breathing-related quality of life.

• Asthma and rescue treatment strategies for patients with difficult-to-control symptoms
• Seasonal allergic rhinitis and pollen-related rhinoconjunctivitis in children and adolescents
• Bronchiectasis and serious viral lung infections, with studies focused on treatment effectiveness and prevention of worsening disease

Research at the site also includes allergy-focused studies for birch and grass pollen, reflecting a broad interest in improving care for common and chronic airway disorders.

Clinical trials in cardiovascular, immune, and digestive system diseases extend into important kidney-related conditions such as chronic kidney disease, IgA nephropathy, Alport syndrome, and focal segmental glomerulosclerosis. These studies are mainly aimed at slowing disease progression and preserving kidney function.

• Chronic kidney disease and proteinuria, with trials assessing kidney protection and disease slowing
• Rare kidney disorders such as Alport syndrome and idiopathic immune complex mediated membranoproliferative glomerulonephritis
• IgA nephropathy and other complement-related conditions, with a focus on improving renal outcomes

These investigations reflect a strong interest in rare and complex kidney diseases, where better treatment options are still needed.

The site participates in research on hemic and lymphatic diseases, immune system diseases, and phenomena and processes involving immune regulation. Trials include hemophilia, primary immunodeficiency diseases, hereditary angioedema, and immune-mediated blood disorders.

• Hemophilia and primary immunodeficiency, with studies evaluating long-term safety and treatment support
• Hereditary angioedema and related swelling attacks, with research focused on prevention and symptom control
• Rare immune and blood disorders such as FNAIT and multifocal motor neuropathy, where new therapies are being tested for effectiveness

This is an important area of rare-disease research at the hospital, supporting patients with conditions that often require specialized, ongoing care.

Research in nervous system diseases includes studies in multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, and chronic migraine. The purpose of these trials is to assess whether new treatments can better control symptoms, reduce relapses, and improve daily functioning.

• Relapsing multiple sclerosis, with attention to relapse prevention and long-term disease control
• CIDP and other immune-related neuropathies, focusing on strength, function, and response maintenance
• Chronic migraine in adolescents, with studies designed to improve prevention of headache episodes

These studies show a clear interest in autoimmune and neurological conditions where sustained symptom relief can make a major difference for patients.

The oncology portfolio covers neoplasms such as non-small cell lung cancer, biliary tract cancer, prostate cancer, multiple myeloma, follicular lymphoma, and chronic lymphocytic leukemia. These trials are generally intended to test new therapies, compare treatment approaches, and improve outcomes in difficult-to-treat cancers.

• Lung cancer and biliary tract cancer, including studies of advanced disease treatment options
• Prostate cancer, with research aimed at slowing progression and extending control after standard treatment
• Blood cancers such as multiple myeloma, follicular lymphoma, and CLL/SLL, where new immune-based and targeted therapies are being evaluated

At Univerzitna Nemocnica Martin, this cancer research supports the search for more effective and better-tolerated options across several advanced malignancies.

Clinical studies in cardiovascular diseases include acute myocardial infarction and chronic heart failure, often alongside kidney and iron-related conditions. The main aim is to evaluate whether new or supportive treatments can lower complications and improve long-term health.

• Anterior ST-elevation myocardial infarction, with research focused on recovery and prevention of later heart problems
• Chronic heart failure, including studies on symptom burden and hospitalization risk
• Related metabolic and kidney-linked conditions, where treatment effectiveness and disease progression are key concerns

These trials show a practical focus on improving outcomes for patients with serious cardiovascular disease, especially when other organs are also affected.